AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
The facility is set to be operational by 2029.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Read Here
Advertise
Sign Up
Commentary
Where does value creation really happen?
Managing the cost of diverging standards: Why Singapore matters
Singapore’s AI ambition has an intelligence problem
Singapore is deploying AI at speed – and security risks are catching up
Precious metal boom is a stress test for Singapore’s gold ambitions
Singapore’s global dispute fault lines
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy